文献速递妇产影像泌尿生殖US

超声定义的子宫腺肌症亚型及其对冻融胚胎移植结局的影响:一项倾向性评分匹配队列研究

Ultrasound-defined adenomyosis subtypes and their impact on outcomes following frozen embryo transfer: a propensity score-matched cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-10-13

这项回顾性单中心队列研究纳入2022年8月至2024年6月首次冻融胚胎移植且移植胚胎为高质量的妇女,按修订MUSA标准用经阴道超声定义子宫腺肌症亚型(外肌层型、内肌层型、混合型),以1:1倾向性评分匹配无腺肌症对照。腺肌症组活产率显著低于对照(35.38% vs 45.16%,P<0.001),内肌层型和混合型活产率降低更明显,早期妊娠丢失率升高;外肌层型活产率与对照无显著差异。

要点

  • 超声诊断腺肌症总体活产率低于对照(35.38% vs 45.16%,P<0.001)。
  • 混合型活产率最低(18.09% vs 44.15%,P<0.001),内肌层型亦降低(27.44% vs 42.33%,P=0.002),外肌层型与对照无显著差异。
  • 腺肌症组早期妊娠丢失率升高(22.25% vs 15.65%,P=0.011)。

核心结论

  • 子宫腺肌症,尤其是内肌层型和混合型,与冻融胚胎移植后活产率降低及临床妊娠后早期妊娠丢失风险升高相关;冻融胚胎移植前基于超声的腺肌症分型可能有助于个体化辅助生殖管理。

研究设计与样本

  • 回顾性单中心队列研究,纳入2022年8月至2024年6月首次冻融胚胎移植且移植胚胎为高质量的妇女,采用经阴道超声按修订MUSA标准诊断腺肌症并分型,1:1倾向性评分匹配(匹配变量:年龄、体重指数、抗苗勒管激素水平、不孕类型、胚胎 stage、不孕原因、FET方案、移植胚胎数),最终纳入腺肌症组879例和匹配对照879例,年龄20至42岁。

诊断标准与关键数值

  • 子宫腺肌症亚型定义:外肌层型局限于子宫外层肌层;内肌层型累及内层肌层(对应子宫内膜-肌层交界处)和/或中层肌层;混合型同时累及内层和外层肌层。主要结局活产定义为≥28周妊娠分娩至少一活婴;早期妊娠丢失定义为<12周。腺肌症组 vs 对照:活产率35.38% vs 45.16%(P<0.001;OR 0.67,95%CI 0.55-0.81);外肌层型45.80% vs 46.85%(P=0.795;OR 0.96,95%CI 0.74-1.24);内肌层型27.44% vs 42.33%(P=0.002;OR 0.52,95%CI 0.34-0.77);混合型18.09% vs 44.15%(P<0.001;OR 0.28,95%CI 0.17-0.45);早期妊娠丢失率22.25% vs 15.65%(占临床妊娠,P=0.011;OR 1.54,95%CI 1.10-2.15)。

临床应用与阅片要点

  • 冻融胚胎移植前超声评估可按修订MUSA标准将腺肌症分为外肌层型、内肌层型和混合型,其中内肌层型和混合型与活产率降低及早期妊娠丢失风险升高相关;作者认为冻融胚胎移植前基于超声的腺肌症分型可能有助于个体化辅助生殖管理。

局限性

  • 原文为回顾性、单中心队列研究。
  • 原文结论指出需要进一步前瞻性研究验证这些结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the association of adenomyosis subtypes defined by ultrasound using the revised Morphological Uterus Sonographic Assessment (MUSA) criteria, with reproductive and obstetric outcomes following frozen embryo transfer (FET).

METHODS: This retrospective, single-center cohort study included women who underwent their first FET cycle, as well as transvaginal ultrasound evaluation for the diagnosis of adenomyosis using the revised MUSA criteria, between August 2022 and June 2024. We included only FET cycles in which transferred embryos were of high quality. Adenomyosis subtypes were defined as follows: external (confined to the outer myometrium), internal (involving the inner myometrium, corresponding to the endometrial-myometrial junction, and/or the middle myometrium) and mixed (affecting both inner and outer myometrium). Controls were selected from women without ultrasound evidence of adenomyosis who underwent FET during the same period. Propensity score matching (1:1) was performed using patient age, body mass index, anti-Müllerian hormone level, infertility type, embryo stage, cause of infertility, FET protocol and number of embryos transferred. Comparative analyses were conducted to assess differences in reproductive and obstetric outcomes in women with adenomyosis, both overall and its subtypes, vs matched controls. The primary outcome was live birth, defined as delivery of at least one live infant at ≥ 28 weeks' gestation. Secondary outcomes were: implantation, clinical pregnancy, ectopic pregnancy, early pregnancy loss (< 12 weeks), late pregnancy loss (12-28 weeks), multiple pregnancy, preterm birth (< 37 weeks), low birth weight (< 2500 g), fetal growth restriction, hypertensive disorders of pregnancy, gestational diabetes mellitus, placenta previa, placenta accreta, placental abruption, premature rupture of membranes and delivery by Cesarean section.

RESULTS: Of 4146 eligible women, 879 with adenomyosis and 879 matched controls without adenomyosis were included in the analysis. Their age ranged from 20 to 42 years. The rate of live birth was significantly lower in the group with adenomyosis compared to controls (35.38% vs 45.16%, P < 0.001; odds ratio (OR), 0.67 (95% CI, 0.55-0.81)). Women with external adenomyosis, accounting for over 50% of cases, had a live-birth rate comparable with that of their matched controls (45.80% vs 46.85%, P = 0.795; OR, 0.96 (95% CI 0.74-1.24)), whereas the live-birth rate was significantly lower for women with internal adenomyosis (27.44% vs 42.33%, P = 0.002; OR, 0.52 (95% CI, 0.34-0.77)) and even lower for those with mixed-type adenomyosis (18.09% vs 44.15%, P < 0.001; OR, 0.28 (95% CI, 0.17-0.45)) compared with controls. The rate of early pregnancy loss was higher in adenomyosis patients compared with controls (22.25% vs 15.65% of clinical pregnancies, P = 0.011; OR, 1.54 (95% CI, 1.10-2.15)). There were no significant differences in most of the other secondary outcomes in women with a live birth, between those with adenomyosis and controls. However, subgroup analysis revealed several significant associations between adenomyosis phenotypes, mainly internal and mixed-type adenomyosis, and specific obstetric outcomes.

CONCLUSIONS: Adenomyosis, particularly internal and mixed-type, is associated with a reduced live-birth rate and an increased risk of early pregnancy loss in those achieving clinical pregnancy following FET. Ultrasound-based phenotyping of adenomyosis prior to FET may support individualized assisted reproductive technology management. Further prospective studies are needed to validate these results. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Wang L, Zheng H, Weng C, et al. Ultrasound-defined adenomyosis subtypes and their impact on outcomes following frozen embryo transfer: a propensity score-matched cohort study. Ultrasound Obstet Gynecol. 2025. PMID: 41081491. doi:10.1002/uog.70102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。